Cited by 147T-cell and B-cell ImmunologyPI3K/AKT/mTOR signaling in cancerDevelopmental Biology and Gene Regulation

Critical roles of the PI3K/Akt signaling pathway in T cell development

Open access
Juntilla, Marisa M., Koretzky, Gary A.·2008·Immunology Letters

Abstract

Thymocyte development requires an integration of extracellular cues to enforce lineage commitment at multiple defined checkpoints in a stage-specific manner. Critical signals from the pre-TCR, Notch, and the receptor for interleukin-7 (IL-7) dictate cellular differentiation from the CD4(-)CD8(-) (double negative) stage to the CD4+CD8+ (double positive) stage. The PI3K/Akt signaling pathway is required to translate these extracellular signaling events into multiple functional outcomes including cellular survival, proliferation, differentiation, and allelic exclusion at the beta-selection checkpoint. However, a complete understanding of the contributions made by the PI3K/Akt pathway in thymocyte development has not been straightforward. This review highlights studies that support the model that the PI3K/Akt pathway is essential for thymocyte survival. We provide new evidence that Akt-mediated survival is not solely due to the increased expression of Bcl-xL but also is a consequence of the role played by Akt to support metabolism in proliferating thymocytes.

Integrity signals

Registry

Crossref · 10.1016/j.imlet.2007.12.008

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Juntilla, M. M., & Koretzky, G. A.
Affiliations
University of Pennsylvania (US)
Venue
Immunology Letters
Publisher
Elsevier BV
Published
2008-03
Volume
116
Issue
2
Pages
104-110
ISSN
0165-2478 (ISSN-L)
OpenAlex
W2061149209
Cited by
147
References
0
Citations by year
2026: 4 · 2025: 10 · 2024: 10 · 2023: 5 · 2022: 11 · 2021: 7 · 2020: 7 · 2019: 8 · 2018: 6 · 2017: 9 · 2016: 3 · 2015: 4 · 2014: 5 · 2013: 7 · 2012: 15
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • Immunology Letters (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Public Health Service (F31 A1056671)
  • National Cancer Institute (P01CA093615)
  • National Institute of General Medical Sciences (R01GM053256)
  • National Institute of Allergy and Infectious Diseases (R01AI058019)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Keywords
PI3K/Akt signaling, T cell development, T cell lineage commitment, pre-TCR signaling, Notch signaling, CD127, beta-selection, allelic exclusion, thymocyte survival, Bcl-xL, cell proliferation
MeSH terms
Pyruvate Dehydrogenase Acetyl-Transferring Kinase, Animals, Cell Differentiation, T-Lymphocytes, Signal Transduction, Protein Serine-Threonine Kinases, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review